NCT04121793View on ClinicalTrials.gov

Objective Quality of Life Detection Validation

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

September 20, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Parkinson Disease
Interventions
DEVICE

Kinesia 360 and Smartphone sensors

Data will be recorded from the Kinesia 360 system and smartphone sensors using the AWARE Framework.

Trial Locations (1)

44131

Great Lakes NeuroTechnologies, Cleveland

Sponsors
All Listed Sponsors
collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

lead

Great Lakes NeuroTechnologies Inc.

INDUSTRY

NCT04121793 - Objective Quality of Life Detection Validation | Biotech Hunter | Biotech Hunter